Literature DB >> 15732260

Multiple sclerosis diagnostic criteria: three years later.

Chris H Polman1, Jerry S Wolinsky, Stephen C Reingold.   

Abstract

New diagnostic criteria for multiple sclerosis (MS) were developed by an International Panel in 2001 and have had wide distribution and discussion since publication. These provided the first formal incorporation of magnetic resonance imaging (MRI) in a diagnosis work-up for patients suspected of having MS. The so-called McDonald criteria have been studied in retrospective and prospective analyses for sensitivity, specificity and utility, and have been proven to compare favourably or to be an improvement upon prior MS diagnostic criteria. The purpose of the current review is to present and evaluate the key studies that have been performed using the McDonald criteria since 2001 and to set the stage for an upcoming re-evaluation of the new criteria based on data-driven information gathered since their development.

Entities:  

Mesh:

Year:  2005        PMID: 15732260     DOI: 10.1191/1352458505ms1135oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  30 in total

1.  [Revision of McDonald's new diagnostic criteria for multiple sclerosis].

Authors:  H Wiendl; B C Kieseier; R Gold; R Hohlfeld; M Bendszus; H-P Hartung
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

2.  Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Authors:  Martin Stangel; Ralf Gold; Achim Gass; Judith Haas; Stefan Jung; Wolfgang Elias; Uwe K Zettl
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

3.  Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Authors:  H Wiendl; K V Toyka; P Rieckmann; R Gold; H-P Hartung; R Hohlfeld
Journal:  J Neurol       Date:  2008-10-29       Impact factor: 4.849

Review 4.  Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.

Authors:  Andrew J Solomon; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

5.  A myelin-specific contrast agent for magnetic resonance imaging of myelination.

Authors:  Luca Frullano; Changning Wang; Robert H Miller; Yanming Wang
Journal:  J Am Chem Soc       Date:  2011-01-25       Impact factor: 15.419

6.  Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.

Authors:  Zheng Liu; Matteo Pardini; Özgür Yaldizli; Varun Sethi; Nils Muhlert; Claudia A M Wheeler-Kingshott; Rebecca S Samson; David H Miller; Declan T Chard
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

7.  Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.

Authors:  Divya Narayanan; Han Cheng; Rosa A Tang; Laura J Frishman
Journal:  Doc Ophthalmol       Date:  2014-10-29       Impact factor: 2.379

8.  [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].

Authors:  Peter Rieckmann
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

9.  Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Authors:  Dan M Waid; Teri Schreiner; Gisela Vaitaitis; Jessica R Carter; John R Corboy; David H Wagner
Journal:  J Neuroimmunol       Date:  2014-03-15       Impact factor: 3.478

10.  Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.

Authors:  Begoña M Escribano; Francisco J Medina-Fernández; Macarena Aguilar-Luque; Eduardo Agüera; Montserrat Feijoo; Fe I Garcia-Maceira; Rafael Lillo; Patricia Vieyra-Reyes; Ana I Giraldo; Evelio Luque; René Drucker-Colín; Isaac Túnez
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.